Exchange: NYSE·Updated 07:34 PM EST

GMED Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 05

Estimated EPS

$1.20

Reported EPS

$1.23

Surprise

+2.77%

Estimated Rev

$792.39M

Reported Rev

$763.72M

Surprise

-3.62%

• Reported GAAP EPS of $1.23 up 4.24% YoY • Reported revenue of $763.72M down -0.69% YoY • Globus Medical updated full-year 2026 revenue guidance to $3.09B from $3.18B to $3.22B, representing 5.1% growth, and reaffirmed non-GAAP diluted EPS guidance of $4.95 to $5.05.

Bullish Takeaway

Globus Medical reported 24% Enabling Technologies revenue growth and 73% more robot and navigation deployments, eight consecutive quarters of adjusted margin expansion, and a $500M repurchase authorization increase.

Bearish Takeaway

Globus Medical reported Q3 sales decreases, set 2026 revenue guidance below its previous range, and identified competition, surgeon product adoption, and sales-personnel retention as risks.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
$1.29
--
--
N/A
Q3 '26
$1.20
$1.23
2.77%
BEAT
Q2 '26
$1.10
$1.34
21.91%
BEAT
Q1 '26
$0.92
$1.12
21.80%
BEAT
Q4 '25
$1.13
$1.28
12.89%
BEAT

Advertisement|Remove ads.